Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Plos One|November 4, 2014
A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNATakuya Awata, Hisakuni Yamashita, Susumu Kurihara, et al.Biochemical and Biophysical Research Communications|July 17, 2013
A low-frequency GLIS3 variant associated with resistance to Japanese type 1 diabetesTakuya Awata, Hisakuni Yamashita, Susumu Kurihara, et al.Journal of Diabetes Investigation|November 12, 2024
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.Journal of Diabetes Investigation|January 7, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.Diabetology International|January 29, 2025
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.Diabetology International|August 5, 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.Diabetology International|January 24, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.Diabetes|February 4, 2011
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetesKaoru Aida, Yoriko Nishida, Shoichiro Tanaka, et al.Diabetology International|January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in JapanYoichi Oikawa, Akira Shimada, Takuya Awata, et al.Diabetology International|January 4, 2019
Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitusMegu Yamaguchi Baden, Akihisa Imagawa, Hiromi Iwahashi, et al.Pageof 10